Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02767492 · ClinicalTrials.gov registry record · NA
Steroid Injection vs. BioDRestore for Patients With Knee OA
A NA study, sponsored by The Hawkins Foundation.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02767492: Completed NA study, sponsored by The Hawkins Foundation.
NCT02767492 is a NA study that has completed, run by The Hawkins Foundation. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02767492, a NA study, has completed, sponsored by The Hawkins Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study will include patients who are diagnosed with knee OA and are recommended for a knee injection. Study subjects will be randomized to receive either the standard of care knee injection (steroid) or amniotic tissue injection (BioDRestore). Study subjects will be asked for permission for a baseline knee aspiration prior to the knee injection. At 6 months post-injection, knee aspirations will be taken and sent for analysis. Study subjects will be followed for 1 year post-injection to include range of motion measurements and patient-reported pain/functional outcome measurements. X-rays will also be taken at the 1-year post-injection appointment.
Primary Outcome
Patient reported level of pain on a scale of 0-10, with 10 being extreme pain and 0 being no pain.
Interventions
- DRUG Kenalog
- DEVICE BioD Restore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-01 |
| Phase | NA |
What the finished NCT02767492 record still lists
NCT02767492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Kenalog is the first listed.
NCT02767492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02767492 about?
NCT02767492 is a clinical study titled "Steroid Injection vs. BioDRestore for Patients With Knee OA". This study will include patients who are diagnosed with knee OA and are recommended for a knee injection. Study subjects will be randomized to receive either the standard of care knee injection (steroid) or amniotic tissue injection (BioDRestore). Study subjects will be asked for permission for a ba...
What is the current status of trial NCT02767492?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2017-01. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02767492?
The interventions under investigation include: Kenalog (DRUG), BioD Restore (DEVICE).
Who is sponsoring clinical trial NCT02767492?
This trial is sponsored by The Hawkins Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02767492's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia